newsfilter
← Latest News
GlobeNewswire·

NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market

ZURICH, Nov. 09, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (NASDAQ:NCEL), a clinical-stage biopharmaceutical company developing stem cell-based therapies for type 1 diabetes, today announced that it has entered into